MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
Over recent decades we have been fortunate to witness the advent of new technologies and of an expanded knowledge and application of chelation therapies to the benefit of patients with iron overload. However, extrapolation of learnings from thalassemia to the myelodysplastic syndromes (MDS) has resu...
Saved in:
| Main Authors: | Emanuele Angelucci, Silvana Anna Maria Urru, Federica Pilo, Alberto Piperno |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2017-03-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/2850 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Efficacy of Chelation Therapy in Patients with Low-Risk Myelodysplastic Syndrome
by: SV Gritsaev, et al.
Published: (2019-03-01) -
Clinical features and outcomes of myelodysplastic syndrome patients with iron overload: a single-center retrospective study
by: Lei Huang, et al.
Published: (2025-07-01) -
New Perspectives on the Impact of Iron Chelation Therapy on the Gut Microbiome in Thalassemia Patients
by: Sara Deumić, et al.
Published: (2025-02-01) -
Comparative study of efficacy of different iron chelating agents in treatment of iron overload in children with Beta Thalassemia Major
by: adel abd elhaleim hagag
Published: (2014-08-01) -
Impact of Sappan Wood Extract as Iron Chelator Adjuvant on Iron Concentration and Macrophage Polarization in Rat Spleen
by: Mohammad Ghozali, et al.
Published: (2025-07-01)